Patent ID: 11969470
Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. A method for treating a subject who has been or is diagnosed at risk for developing a condition selected from the group consisting of ischemic stroke, neonatal anoxia, conditions caused by exposure to sarin, neonatal seizures, simple partial seizures, complex partial seizures, secondarily generalized seizures, generalized seizures, typical absence seizures, atypical absence seizures, myoclonic seizures, tonic seizures, clonic seizures, generalized tonic-clonic seizures, atonic seizures, and seizures associated with juvenile myoclonic epilepsy, the method consisting essentially of administering to the subject an effective amount of a composition consisting of topiramate or a salt thereof, a compound of Formula I:, wherein: n is 4, 5 or 6; R1, R2, R3, R4, R5, R6, R7, R8 and R9 are each, independently, —O— or a —O—(C2-C6 alkylene)-SO3− group, wherein at least one of R1 and R2 is independently a —O—(C2-C6 alkylene)-SO3− group; and S1, S2, S3, S4, S5, S6, S7, S8 and S9 are each, independently, H or a pharmaceutically acceptable cation and an additional pharmaceutically acceptable carrier.